About Dr. Yuan Yaozong
Dr. Yuan Yaozong (袁耀宗) is one of China's foremost gastroenterologists and a nationally recognized authority on pancreatic disease, inflammatory bowel disease, and advanced endoscopy. He serves as Director of the Department of Gastroenterology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and holds the title of Chief Physician and Professor.
With a clinical and research career spanning over three decades, Dr. Yuan has established Ruijin Hospital's Gastroenterology Department as one of the premier digestive disease centers in China. He is particularly renowned for his expertise in acute and chronic pancreatitis, pancreatic cancer, and therapeutic endoscopy — areas where his contributions have shaped national clinical guidelines and influenced practice across Asia.
International patients with complex gastrointestinal conditions — including pancreatic disease, inflammatory bowel disease, and gastrointestinal cancers — consistently identify Dr. Yuan as one of China's top specialists for second opinions and primary treatment.
Professional Positions and Affiliations
- Director, Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Chairman, Pancreatic Disease Committee, Chinese Society of Gastroenterology
- Vice President, Chinese Society of Gastroenterology
- Editorial Board Member: Gut, Pancreatology, Journal of Gastroenterology and Hepatology
- Member, International Association of Pancreatology (IAP)
- Member, American Pancreatic Association (APA)
- Principal Investigator, multiple national and international multicenter clinical trials in pancreatology and IBD
Specialties and Clinical Expertise
Dr. Yuan's clinical practice covers the full breadth of gastroenterology and hepatology, with particular depth in pancreatic disease and advanced endoscopic intervention. His approach integrates cutting-edge endoscopic techniques with multidisciplinary medical and surgical management.
- Acute Pancreatitis — severity stratification, intensive care coordination, endoscopic and minimally invasive necrosectomy for infected pancreatic necrosis, and prevention of recurrence
- Chronic Pancreatitis — pain management, endoscopic therapy (pancreatic duct stenting, stone extraction, pseudocyst drainage), and surgical referral for refractory cases
- Pancreatic Cancer — early detection, staging, multidisciplinary treatment planning, and palliative endoscopic biliary and duodenal stenting
- Autoimmune Pancreatitis (AIP) — diagnosis and steroid therapy; differentiation from pancreatic cancer
- Inflammatory Bowel Disease (IBD) — Crohn's disease and ulcerative colitis; biologic therapy (anti-TNF, vedolizumab, ustekinumab, JAK inhibitors), treat-to-target protocols, and endoscopic mucosal healing assessment
- Advanced Therapeutic Endoscopy — ERCP (endoscopic retrograde cholangiopancreatography), EUS (endoscopic ultrasound) with fine-needle aspiration and biopsy, ESD (endoscopic submucosal dissection) for early gastric and colorectal cancer, and POEM (per-oral endoscopic myotomy) for achalasia
- Gastrointestinal Cancers — early detection and endoscopic resection of gastric, colorectal, and esophageal cancers; coordination with oncology and surgery for advanced disease
- Functional Gastrointestinal Disorders — irritable bowel syndrome (IBS), functional dyspepsia, and gastroparesis; evidence-based management including gut microbiome-targeted therapies
- Liver Disease — chronic hepatitis B and C, non-alcoholic fatty liver disease (NAFLD/NASH), and cirrhosis management
Academic and Research Contributions
Dr. Yuan Yaozong has published over 250 peer-reviewed papers in leading international gastroenterology journals, with a particular focus on the pathogenesis and management of acute pancreatitis and the optimization of biologic therapy for inflammatory bowel disease. His research on the Chinese epidemiology of pancreatitis — including the distinct etiological profile (hypertriglyceridemia-induced pancreatitis is far more prevalent in China than in Western populations) — has been instrumental in developing China-specific management guidelines.
He has led landmark multicenter trials on the management of severe acute pancreatitis, early enteral nutrition protocols, and minimally invasive approaches to pancreatic necrosis. His work on EUS-guided drainage of pancreatic fluid collections has been adopted as standard practice across China and referenced in international guidelines.
Dr. Yuan chairs the Pancreatic Disease Committee of the Chinese Society of Gastroenterology and has been the lead author on multiple editions of China's national pancreatitis clinical guidelines. He is a regular invited speaker at Digestive Disease Week (DDW), United European Gastroenterology Week (UEGW), and the Asian Pacific Digestive Week (APDW).
Approach to Patient Care
Dr. Yuan is known for his systematic, evidence-driven approach to complex gastrointestinal cases. He leads a multidisciplinary team that brings together gastroenterologists, pancreatic surgeons, interventional radiologists, nutritionists, and oncologists to develop comprehensive management plans for patients with complex pancreatic or IBD-related conditions.
For international patients — many of whom arrive with prior diagnoses from overseas institutions — Dr. Yuan takes particular care to review all available imaging, pathology, and laboratory data before forming an independent clinical opinion. His willingness to engage with complex second opinion requests, and his familiarity with international treatment standards, makes him an ideal consultant for patients who have been treated abroad and are seeking expert validation or alternative approaches.
Hospital: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Ruijin Hospital is one of China's most prestigious academic medical centers, consistently ranked among the top hospitals nationally by the National Health Commission. Founded in 1907, the hospital has over a century of clinical excellence across all major specialties.
The Department of Gastroenterology at Ruijin is a National Key Clinical Specialty and one of the busiest and most technically advanced digestive disease centers in China. The department operates:
- A high-volume Endoscopy Center performing over 50,000 procedures annually, including advanced therapeutic endoscopy (ERCP, EUS, ESD, POEM)
- A dedicated Pancreatitis Intensive Care Unit for severe acute pancreatitis management
- A Multidisciplinary IBD Clinic with gastroenterology, colorectal surgery, radiology, and nutrition
- A Pancreatic Disease Multidisciplinary Team (MDT) meeting weekly for complex pancreatic cancer and pancreatitis cases
- A Clinical Trials Unit running multiple Phase II-III studies in IBD, pancreatology, and GI oncology
Why International Patients Choose Dr. Yuan Yaozong
- China's leading pancreatologist — national guideline author and IAP/APA member
- Advanced endoscopy expertise — ERCP, EUS, ESD, and POEM at the highest technical level
- IBD biologic therapy leader — access to the full range of approved and investigational biologics
- Hypertriglyceridemia pancreatitis specialist — a condition disproportionately common in Asian patients and often mismanaged elsewhere
- Second opinion authority — regularly reviews complex overseas cases for international patients
- High-volume center — Ruijin Gastroenterology's case volume translates to unmatched procedural expertise
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Appointment Lead Time: 2–4 weeks for new patients; urgent or acute cases may be expedited through CMCS
- Consultation Format: In-person consultation; remote pre-consultation record review available through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Medical Records: CMCS provides full translation of overseas medical records, imaging reports, and pathology into Chinese prior to consultation
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking consultation or treatment with Dr. Yuan Yaozong at Ruijin Hospital. Our services include:
- Priority appointment booking and scheduling coordination
- Medical record and imaging report translation (English ↔ Chinese)
- Remote pre-consultation record review facilitation
- On-site interpretation during consultations and endoscopic procedures
- Accommodation coordination near Ruijin Hospital
- Insurance liaison and billing support
- Post-treatment follow-up coordination with your home country gastroenterologist
- Clinical trial eligibility assessment for IBD and pancreatic disease studies
📧 Contact us: contract@medicalsh.com
💬 WeChat: gezhanglao
🌐 medicalsh.com
0 commentaire